Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ertapenem
Drug ID BADD_D00802
Description Ertapenem is a carbapenem antibiotic drug that is marketed under the trade name Invanz by Merck & Co. pharmaceutical company. It is structurally similar to [meropenem] and possesses a 1-beta-methyl group.
Indications and Usage For the treatment the following moderate to severe infections caused by susceptible isolates of the designated microorganisms: (1) complicated intra-abdominal infections due to Escherichia coli, Clostridium clostridioforme, Eubacterium lentum, Peptostreptococcus species, Bacteroides fragilis, Bacteroides distasonis, Bacteroides ovatus, Bacteroides thetaiotaomicron, or Bacteroides uniformis, (2) complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis due to Staphylococcus aureus (methicillin susceptible isolates only), Streptococcus agalactiae, Streptococcus pyogenes, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Bacteroides fragilis, Peptostreptococcus species, Porphyromonas asaccharolytica, or Prevotella bivia, (3) community acquired pneumonia due to Streptococcus pneumoniae (penicillin susceptible isolates only) including cases with concurrent bacteremia, Haemophilus influenzae (beta-lactamase negative isolates only), or Moraxella catarrhalis, (4) complicated urinary tract infections including pyelonephritis due to Escherichia coli, including cases with concurrent bacteremia, or Klebsiella pneumoniae, (5) acute pelvic infections including postpartum endomyometritis, septic abortion and post surgical gynecologic infections due to Streptococcus agalactiae, Escherichia coli, Bacteroides fragilis, Porphyromonas asaccharolytica, Peptostreptococcus species, or Prevotella bivia.
Marketing Status Prescription
ATC Code J01DH03
DrugBank ID DB00303
KEGG ID D07908
MeSH ID D000077727
PubChem ID 150610
TTD Drug ID D0Q1MS
NDC Product Code 55150-282; 16714-889; 44567-820; 0409-3510; 43598-901
Synonyms Ertapenem | Invanoz | Invanz | Ertapenem Sodium
Chemical Information
Molecular Formula C22H25N3O7S
CAS Registry Number 153832-46-3
SMILES CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Haemoptysis02.01.02.006; 24.07.01.006; 22.02.03.004--Not Available
Haemorrhoids24.10.02.002; 07.15.03.001--
Hallucination19.10.02.0020.002874%
Hallucination, auditory19.10.02.0030.000532%Not Available
Hallucination, visual19.10.02.0040.001277%Not Available
Hallucinations, mixed19.10.02.0070.000319%Not Available
Headache17.14.01.001--
Hemiparesis17.01.04.0010.000213%
Hepatitis09.01.07.0040.000213%Not Available
Hepatitis acute09.01.07.0050.000213%Not Available
Hepatocellular injury09.01.07.0080.000319%Not Available
Herpes simplex11.05.02.001; 23.09.03.001--Not Available
Hiccups07.01.06.009; 22.02.04.002--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hyperkalaemia14.05.03.0010.000213%
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypoaesthesia17.02.06.023--Not Available
Hypoglycaemia14.06.03.001; 05.06.03.001--
Hypokinesia17.01.02.0090.000213%Not Available
Hypotension24.06.03.0020.000532%
Hypothermia12.05.03.001; 08.05.01.003--
Hypoxia22.02.02.003--
Ileus07.13.01.001--
Immune system disorder10.02.01.001--Not Available
Infection11.01.08.002--Not Available
Injection site erythema08.02.03.001; 23.03.06.015; 12.07.03.001--Not Available
Injection site induration12.07.03.007; 08.02.03.007--Not Available
Injection site pain12.07.03.011; 08.02.03.010--Not Available
Insomnia19.02.01.002; 17.15.03.002--
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 13 Pages